We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.62B
AUM Growth
+$874M
Cap. Flow
+$401M
Cap. Flow %
7.12%
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
1.5 quarters
Top 20 Avg Time Held Equity + Options
1.3 quarters
Avg Time Held Equity only
4.1 quarters
Top 10 Avg Time Held Equity only
1.5 quarters
Top 20 Avg Time Held Equity only
1.3 quarters

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$779M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$358M
3
NEWR
New Relic, Inc.
NEWR
+$258M
4
DEN
Denbury Inc.
DEN
+$175M
5
VMW
VMware, Inc
VMW
+$165M

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$230M
2
PDCE
PDC Energy, Inc.
PDCE
+$221M
3
UNVR
Univar Solutions Inc.
UNVR
+$219M
4
FOCS
Focus Financial Partners Inc. Class A
FOCS
+$146M
5
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$141M

Sector Composition

Rank Sector Weight
1 Technology 39.86%
2 Healthcare 28.77%
3 Miscellaneous 7.24%
4 Real Estate 5.15%
5 Financials 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
EWZ icon
426
CALL
iShares MSCI Brazil ETF
EWZ
$10.2B
$233K ﹤0.01%
+500,000
New +$15.9M
2023 Q3
0 quarters
CVNA icon
427
PUT
Carvana
CVNA
$45.9B
$230K ﹤0.01%
5,000,000
– –
2023 Q1
2 quarters
SRPT icon
428
CALL
Sarepta Therapeutics
SRPT
$1.89B
$229K ﹤0.01%
+10,000
New +$1.13M
2023 Q3
0 quarters
ALLY icon
429
PUT
Ally Financial
ALLY
$11.4B
$228K ﹤0.01%
+175,000
New +$4.89M
2023 Q3
0 quarters
TDC icon
430
Teradata
TDC
$2.84B
$225K ﹤0.01%
5,000
– –
2023 Q1
2 quarters
CHGG icon
431
Chegg
CHGG
$81.7M
$223K ﹤0.01%
25,000
– –
2023 Q1
2 quarters
THO icon
432
PUT
Thor Industries
THO
$3.3B
$212K ﹤0.01%
+75,000
New +$7.83M
2023 Q3
0 quarters
IOVA icon
433
CALL
Iovance Biotherapeutics
IOVA
$6.62B
$190K ﹤0.01%
+230,000
New +$1.5M
2023 Q3
0 quarters
NRDY icon
434
Nerdy
NRDY
$55.8M
$185K ﹤0.01%
+3,333
New +$217K
2023 Q3
0 quarters
SNDX icon
435
CALL
Syndax Pharmaceuticals
SNDX
$1.52B
$174K ﹤0.01%
+80,000
New +$1.51M
2023 Q3
0 quarters
MGM icon
436
PUT
MGM Resorts International
MGM
$7.36B
$162K ﹤0.01%
35,000
– –
2023 Q1
2 quarters
USB icon
437
PUT
US Bancorp
USB
$88.9B
$157K ﹤0.01%
+170,000
New +$6.19M
2023 Q3
0 quarters
VLO icon
438
PUT
Valero Energy
VLO
$125B
$155K ﹤0.01%
+40,000
New +$5.24M
2023 Q3
0 quarters
AKTS icon
439
DELISTED
Akoustis Technologies Inc
AKTS
$151K ﹤0.01%
200,000
– –
2022 Q4
3 quarters
ADT icon
440
PUT
ADT
ADT
$4.7B
$142K ﹤0.01%
35,600
– –
2021 Q2
9 quarters
EIGR
441
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$120K ﹤0.01%
13,133
– –
2022 Q1
6 quarters
M icon
442
PUT
Macy's
M
$5.92B
$119K ﹤0.01%
131,000
+18,500
+16% +$259K
2021 Q2
9 quarters
ACRS icon
443
CALL
Aclaris Therapeutics
ACRS
$564M
$117K ﹤0.01%
+70,000
New +$598K
2023 Q3
0 quarters
VTYX icon
444
PUT
DELISTED
Ventyx Biosciences
VTYX
$116K ﹤0.01%
+35,000
New +$1.21M
2023 Q3
0 quarters
REPL icon
445
CALL
Replimune Group
REPL
$1.26B
$115K ﹤0.01%
+40,000
New +$786K
2023 Q3
0 quarters
SYBX icon
446
DELISTED
Synlogic
SYBX
$114K ﹤0.01%
40,548
-1
-0% -$7
2022 Q1
6 quarters
VTYX icon
447
CALL
DELISTED
Ventyx Biosciences
VTYX
$113K ﹤0.01%
+30,000
New +$1.04M
2023 Q3
0 quarters
CPRI icon
448
PUT
Capri Holdings
CPRI
$1.7B
$111K ﹤0.01%
13,900
-4,300
-24% -$195K
2021 Q2
9 quarters
RARE icon
449
CALL
Ultragenyx Pharmaceutical
RARE
$1.53B
$109K ﹤0.01%
95,000
+85,000
+850% +$3.37M
2023 Q2
1 quarter
NCLH icon
450
PUT
Norwegian Cruise Line
NCLH
$7.15B
$107K ﹤0.01%
55,100
– –
2021 Q2
9 quarters
16 17
18
19 20

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q3 2023 Portfolio in Review

As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

UBS O'Connor deployed $401M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 16% a quarter earlier, followed by Healthcare and Miscellaneous.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.

  • UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
  • UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
  • UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
  • UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
  • UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
  • UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
  • UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.